TheraRadar
← Back
Data updated: Mar 29, 2026

ESI

OncologyRespiratoryInfectious Disease
Generics

ESI is a generic drug manufacturer focused on Oncology, Respiratory, Infectious Disease.

1987
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 39%
0 drugs Phase 3: 11 Phase 2: 42 Phase 1: 162
Respiratory 23%
0 drugs Phase 3: 21 Phase 2: 23 Phase 1: 37
Infectious Disease 15%
0 drugs Phase 3: 10 Phase 2: 20 Phase 1: 29
Immunology 12%
0 drugs Phase 3: 9 Phase 2: 19 Phase 1: 18
Neurology 11%
0 drugs Phase 3: 12 Phase 2: 13 Phase 1: 8

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

GSK big-pharma
Infectious Disease, Respiratory, Oncology, Immunology, Neurology
AbbVie big-pharma
Immunology, Oncology, Neurology, Infectious Disease
Sanofi big-pharma
Oncology, Infectious Disease, Immunology, Respiratory
Roche big-pharma
Oncology, Neurology, Immunology, Respiratory
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Infectious Disease, Neurology